Creatine and creatinine are commonly measured in biological samples for clinical, pharmaceutical, and research applications. While many chromatographic methods have been developed for urine analysis, laboratories frequently ask whether similar approaches can be applied to EDTA plasma samples.

The answer depends largely on sample matrix effects, analyte recovery, and whether the anticoagulant used during sample collection interferes with the chromatographic separation or detection method.

Can EDTA Plasma Be Used for Creatine and Creatinine Analysis?

Based on previous creatine and creatinine separations, EDTA plasma samples may be suitable for analysis using HPLC methods. However, performance should be verified under the specific chromatographic conditions being used.

Since plasma is a significantly different matrix than urine, method optimization and validation are recommended before routine use.

Potential factors to evaluate include:

• EDTA retention characteristics
• Matrix interferences
• Sample recovery
• Peak resolution
• Detector response
• Method sensitivity

Because EDTA behavior may vary depending on chromatographic conditions, its effect on the separation should be investigated during method development.

Effect of Sample Matrix

Urine and plasma present different analytical challenges.

Compared to urine, plasma contains:

• Proteins
• Lipids
• Endogenous metabolites
• Additional matrix components

These substances may influence:

• Retention times
• Peak shape
• Detector response
• Overall method robustness

For this reason, successful analysis in urine does not automatically guarantee identical performance in plasma.

Mobile Phase Considerations

Experience with creatine and creatinine separations suggests that incorporating a mobile phase containing:  50:50 Methanol / Water  may be beneficial when working with plasma samples.

This solvent composition may help improve chromatographic performance and reduce matrix-related challenges encountered with biological samples.  Method optimization should always be performed using actual samples and analytical conditions representative of the intended application.

Method Development Recommendations

When evaluating creatine and creatinine in EDTA plasma, consider:

• Assessing EDTA retention behavior
• Evaluating matrix effects
• Monitoring peak resolution
• Confirming analyte recovery
• Verifying method linearity
• Assessing method precision and accuracy
• Optimizing sample preparation procedures

These steps can help determine whether the existing method is suitable for plasma analysis or requires modification.

Related Application Information

For laboratories interested in creatine and creatinine chromatography, a related application note is available:  View the Creatine and Creatinine Analysis Application Note

Conclusion

EDTA plasma samples may be suitable for creatine and creatinine analysis by HPLC, although method suitability should be confirmed for the specific sample matrix and analytical conditions. While previous work has demonstrated successful creatine and creatinine separations, evaluation of EDTA behavior, matrix effects, and recovery is recommended when transferring the method from urine to plasma samples.